Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px

News > All

Total search results: 6736 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 66 67 68  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Novartis AG. (5/28/22). "Press Release: FDA Approves Novartis Kymriah CAR-T Cell Therapy for Adult Patients with Relapsed or Refractory Follicular Lymphoma". Basel. 2022-05-28
Max Planck Society. (5/27/22). "Press Release: Amazon and Max Planck Society Establish Science Hub". 2022-05-27
CureVac N.V.. (5/25/22). "Press Release: CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development". Tübingen & Ghent. 2022-05-25
Alithea Genomics. (5/24/22). "Press Release: Alithea Genomics Raises CHF 1 Million in Seed Financing Round led by Novalis Biotech". Lausanne. 2022-05-24
Evotec SE. (5/19/22). "Press Release: Evotec and Almirall Enter into a Multi-target Alliance in Medical Dermatology". Hamburg & Barcelona. 2022-05-19
Formycon AG. (5/19/22). "Press Release: Formycon Appoints Dr. Stefan Glombitza as CEO and Sets the Course for the Future by Appointing the Two Experienced Pharmaceutical Managers Nicola Mikulcik and Dr. Andreas Seidl to the Executive Board". Munich. 2022-05-19
Synexa Life Sciences B.V.. (5/19/22). "Press Release: Synexa Life Sciences Acquires Finnish CRO Syrinx Bioanalytics to Expand Bioanalysis Capabilities". Leiden. 2022-05-19
Atara Biotherapeutics, Inc.. (5/19/22). "Press Release: Atara Biotherapeutics Provides Update on Strategic Collaboration with Bayer". South San Francisco, CA. 2022-05-19
Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden. 2022-05-18
NanoTemper Technologies GmbH. (5/18/22). "Press Release: NanoTemper Technologies Welcomes Andreas Schmitz as Its First Chief Human Resources Officer". Munich. 2022-05-18
Avantium N.V.. (5/17/22). "Press Release: Avantium Awarded €3 Million EU Grant to Demonstrate the Electrochemical Conversion of CO2 to Consumer Products". Amsterdam. 2022-05-17
Evotec SE. (5/17/22). "Press Release: Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a 'Functional Cure' for Diabetes". Hamburg & London, ON. 2022-05-17
BeiGene, Ltd.. (5/17/22). "Press Release: BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland". Cambridge, MA, Basel & Beijing. 2022-05-17
Nouscom AG. (5/17/22). "Press Release: Nouscom Announces Janssen Receives US FDA IND Clearance for VAC85135, an ‘Off-The-Shelf’ Cancer Immunotherapy Developed using Nouscom’s Proprietary Viral Vector Platform". Basel. 2022-05-17
HH2E AG. (5/16/22). "Press Release: HH2E Concludes Equity Raising Round with HydrogenOne and Foresight and Secures Funding Agreement for Five Large Scale Projects". 2022-05-16
Proteros Biostructures GmbH. (5/16/22). "Press Release: Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca". Munich. 2022-05-16
Sofinnova Partners. (5/16/22). "Press Release: Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences". New York, NY & Paris. 2022-05-16
Valneva S.E.. (5/16/22). "Press Release: Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement". Saint-Herblain. 2022-05-16
Enzymaster Deutschland GmbH. (5/12/22). "Press Release: Enzymaster Completes Round-C Financing to Accelerate Innovation, Increase Capabilities, and Expand Capacity". Düsseldorf. 2022-05-12
Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. 2022-05-12
SciRhom GmbH. (5/12/22). "Press Release: SciRhom Announces Addition to the Management Team". Munich. 2022-05-12
Sofinnova Partners. (5/12/22). "Press Release: Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform". Milan. 2022-05-12
Qiagen N.V.. (5/11/22). "Press Release: Qiagen Acquires Majority Stake in Enzymes Provider BLIRT S.A.". Hilden & Germantown, MD. 2022-05-11
Proteona Pte. Ltd.. (5/11/22). "Press Release: Proteona Opens New Laboratory in Singapore. New Facility Will also Serve as Regional Headquarters for Singleron in Asia". Singapore. 2022-05-11
Artax Biopharma, Inc.. (5/11/22). "Press Release: Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases". Cambridge, MA. 2022-05-11
Qiagen N.V.. (5/11/22). "Press Release: Qiagen Proposes Expansion of Supervisory Board. Dr. Eva Pisa Proposed as a New Member to the Supervisory Board". Venlo. 2022-05-11
Evotec SE. (5/10/22). "Press Release: Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation". Hamburg. 2022-05-10
Bruker Corporation. (5/10/22). "Press Release: Bruker and TOFwerk Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets". Thun. 2022-05-10
ADC Therapeutics S.A.. (5/9/22). "Press Release: ADC Therapeutics Announces CEO Transition. Co-Founder Chris Martin Transitions CEO Role to Industry Veteran Ameet Mallik". Lausanne. 2022-05-09
SHS Gesellschaft für Beteiligungsmanagement mbH. (5/9/22). "Press Release: SHS Strengthens Finance Team. Lukas Maucher Joins Tübingen-based Private Equity Investor as CFO". 2022-05-09
InxMed Co., Ltd.. (5/9/22). "Press Release: InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers". Nanjing. 2022-05-09
NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL. 2022-05-09
Bruker Corporation. (5/9/22). "Press Release: Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets". London. 2022-05-09
Sidekick Health. (5/5/22). "Press Release: Sidekick Raises $55M Series B to Drive Further Growth". Berlin, Boston & Reykjavik. 2022-05-05
European Spatial Biology Center (ESBC). (5/4/22). "Press Release: The European Spatial Biology Center (ESBC). State-of-the-Art Spatial Biology Services Enabled at Scale in Leuven". 2022-05-04
Coriolis Pharma Research GmbH. (5/4/22). "Press Release: Coriolis Pharma Appoints Silvia Steyrer-Gruber as New Chief Executive Officer". Martinsried. 2022-05-04
Swiss Biotech Association. (5/3/22). "Press Release: Swiss Biotech Association Elects Molecular Partners’ CEO Patrick Amstutz as President of the Board of Directors". 2022-05-03
Byondis B.V.. (5/3/22). "Press Release: Byondis and Medac Enter into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)". Nijmegen & Wedel. 2022-05-03
Tubulis GmbH. (5/3/22). "Press Release: Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies". Munich. 2022-05-03
Engimmune Therapeutics AG. (5/3/22). "Press Release: Engimmune Therapeutics Raises CHF 15.5 Million in Seed Financing to Develop Novel T-cell Receptor Therapeutics". Basel. 2022-05-03
Corden Pharma International GmbH. (5/2/22). "Press Release: Astorg to Acquire Leading Pharmaceutical Contract Development & Manufacturing Organization CordenPharma from ICIG". Basel. 2022-05-02
Selexis S.A.. (5/2/22). "Press Release: JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA". Sunnyvale, CA. 2022-05-02
Merck KGaA. (4/29/22). "Press Release: Merck Invests Approximately € 100 Million to Accelerate Single-Use Manufacturing in China". Darmstadt. 2022-04-29
Bionter AG. (4/27/22). "Press Release: Bionter AG Secures $3 Million in Series Seed Financing Led by Dynamk Capital". Riehen. 2022-04-27
Mainz Biomed N.V.. (4/26/22). "Press Release: Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer". Berkeley, CA & Mainz. 2022-04-26
Bico Group AB. (4/26/22). "Press Release: BICO’s CFO Gusten Danielsson Leaves His Assignment". 2022-04-26
Berlin, State of. (4/26/22). "Press Release: Memorandum Signed on Establishing a Center of Gene and Cell Therapy – The State of Berlin, Bayer, and Charité Are Planning a Health Care Lighthouse Project in the Mitte Borough". Berlin. 2022-04-26
Apeiron Biologics AG. (4/26/22). "Press Release: Apeiron Shareholders Approve New Group Structure Geared towards Enabling Innovation and Growth". Vienna. 2022-04-26
Biotest AG. (4/25/22). "Press Release: Grifols Acquires Majority of Voting Rights in Biotest". Dreieich. 2022-04-25
Valneva S.E.. (4/25/22). "Press Release: Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate". Saint-Herblain. 2022-04-25
Eppendorf SE. (4/22/22). "Press Release: Eppendorf Builds New Site in Wismar for High-tech Polymers Used in Laboratories". Wismar & Hamburg. 2022-04-22
Bayer AG. (4/22/22). "Press Release: Bayer to Create Ag Biologicals Powerhouse Partnership with Ginkgo Bioworks, Advancing Joyn Bio Technology Platforms". Monheim. 2022-04-22
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/22/22). "Press Release: SHS and Yabeo Invest in the Leading Scandinavian Digital Health Platform Dr.Dropin". Tübingen & Oslo. 2022-04-22
CureVac N.V.. (4/21/22). "Press Release: CureVac and GSK’s Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study". Tübingen & Boston, MA. 2022-04-21
Bayer AG. (4/2122). "Press Release: Bayer Appoints Tara Frenkl as the New Head of Oncology Development at Its Oncology Strategic Business Unit". Berlin. 2022-04-21
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/21/22). "Press Release: SHS Sells Shares in Bochum-based Phenox GmbH, a Leading Manufacturer of Instruments and Implants for the Treatment of Stroke". Tübingen. 2022-04-21
VIB, Flanders Interuniversity Institute of Biotechnology. (4/20/22). "Press Release: Christine Durinx Joins VIB as Co-Managing Director". 2022-04-20
Carl Zeiss Meditec AG. (4/19/22). "Press Release: Carl Zeiss Meditec Acquires Two Manufacturers of Surgical Instruments". Jena. 2022-04-19
Symrise AG. (4/14/22). "Press Release: Symrise Successfully Places €750 million ESG-linked Promissory Loan Notes". Holzminden. 2022-04-14
Affimed N.V.. (4/13/22). "Press Release: Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares". Heidelberg. 2022-04-13
Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin. 2022-04-13
Cimeio Therapeutics AG. (4/13/22). "Press Release: Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A". Basel & Boston, MA. 2022-04-13
Oxford BioTherapeutics Ltd.. (4/13/22). "Press Release: Oxford BioTherapeutics Grants Third Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to a Novel Oncology Target". Oxford & San Jose, CA. 2022-04-13
CDR-Life AG. (4/13/22). "Press Release: CDR-Life Announces $76 Million Raised in Series A Funding". Zürich. 2022-04-13
Affimed N.V.. (4/12/22). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. 2022-04-12
CureVac N.V.. (4/11/22). "Press Release: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government". Tübingen & Boston, MA. 2022-04-11
BioNTech SE. (4/11/22). "Press Release: BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines". Mainz & Beminster, NJ. 2022-04-11
Affimed N.V.. (4/10/22). "Press Release: Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting". Heidelberg. 2022-04-10
Mireca Medicines GmbH. (4/8/22). "Press Release: Mireca Signs Transformative Deal with Nasdaq-listed Graybug Vision". Tübingen. 2022-04-08
Affimed N.V.. (4/8/22). "Press Release: Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors". Heidelberg. 2022-04-08
H. Lundbeck A/S. (4/8/22). "Press Release: Joerg Hornstein to Join Lundbeck as Chief Financial Officer and Head of Corporate Functions". Valby. 2022-04-08
IonSense, Inc.. (4/7/22). "Press Release: IonSense, a Leader In DART Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development". New York, NY, London & Research Triangle Park, NC. 2022-04-07
NanoTemper Technologies GmbH. (4/6/22). "Press Release: NanoTemper Technologies and PharmAI Launch Proto, a Free AI Tool to Quickly Determine which Protein Labeling Strategy Works Best for Molecular Interaction Measurements". Munich & Dresden. 2022-04-06
Balderton Capital. (4/6/22). "Press Release: Avi Medical Raises €50M to Put Preventative Healthcare and Digital Integration at Heart of Its Service". 2022-04-06
Catalent, Inc.. (4/6/22). "Press Release: Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe". Somers, NJ. 2022-04-06
ViGeneron GmbH. (4/6/22). "Press Release: ViGeneron Signs Gene Therapy Strategic Collaboration and Option Agreement with Regeneron for One Inherited Retinal Disease Target". Munich. 2022-04-06
Bruker Corporation. (4/5/22). "Press Release: Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies". Billerica, MA. 2022-04-05
Merck KGaA. (4/5/22). "Press Release: Merck Advances BioProcessing Capabilities with Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System". Darmstadt. 2022-04-05
Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. 2022-04-04
Oxford Gene Technology Ltd.. (4/4/22). "Press Release: OGT Welcomes Adrian Smith as CEO". Oxford. 2022-04-04
AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments". 2022-04-04
Novartis AG. (4/4/22). "Press Release (Ad hoc): Novartis Announces New Organizational Structure to Accelerate Growth, Strengthen Pipeline and Increase Productivity". Basel. 2022-04-04
Bayer AG. (4/1/22). "Press Release: Breakthrough Innovation Forum. Bayer Set to Drive Breakthrough Innovations in the Life Sciences". Leverkusen. 2022-04-01
Biovox GmbH. (4/22). "Press Release: Successful Pre-Seed-Round for BIOVOX". 2022-04-01
High-Tech Gründerfonds Management GmbH. (3/31/22). "Press Release: Improving ARDS Treatment with Digital Twins. Ebenbuild Secures Seed Financing Round Led by Bayern Kapital and High-Tech Gründerfonds". Munich, Bonn & Landshut. 2022-03-31
Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg. 2022-03-31
Oxford Science Enterprises. (3/31/22). "Press Release: Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments". 2022-03-31
Bayer AG. (3/31/22). "Press Release: Bayer to Strengthen Global Pharmaceuticals Production Network. Planned Investments of around €2bn over Next Three Years [Not intended for U.S. and UK Media]". Berlin. 2022-03-31
Neuron23 Inc.. (3/30/22). "Press Release: Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease". South San Francisco, CA. 2022-03-30
VectivBio Holding AG. (3/30/22). "Press Release: VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts". Basel. 2022-03-30
CureVac N.V.. (3/30/22). "Press Release: CureVac and GSK Start Clinical Development of Second-generation COVID-19 Vaccine Candidate, CV2CoV". Tübingen & Boston, MA. 2022-03-30
Cytosurge AG. (3/30/22). "Press Release: Cytosurge Launches Cell Line Engineering Services Based on Proprietary FluidFM Technology". Zurich. 2022-03-30
XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". 2022-03-29
Sanofi S.A.. (3/29/22). "Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets". Paris. 2022-03-29
Core Biogenesis S.A.S.. (3/29/22). "Press Release: Core Biogenesis Raises €10M from XAnge and Blue Horizon Ventures to Accelerate Treatment of Cancer and Neurodegenerative Diseases". 2022-03-29
Lonza Group Ltd.. (3/23/22). "Press Release: Christian Seufert Appointed as President of Capsules and Health Ingredients Division". Basel. 2022-03-23
ITM Isotope Technologies Munich SE. (3/22/22). "Press Release: ITM Receives EUR 33 Million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals". Garching. 2022-03-22
Veraxa Biotech GmbH. (3/22/22). "Press Release: Torsten Buergermeister Joins Veraxa Biotech GmbH as Chief Financial Officer". Heidelberg. 2022-03-22
Nucleai MD. (3/22/22). "Press Release: Nucleai Closes $33 Million Series B Financing to Advance Spatial Biology Platform for Drug Research, Development and Diagnostics". Tel Aviv. 2022-03-22
Bayer AG. (3/22/22). "Press Release: Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations". Tel Aviv. 2022-03-22
next pagenext page 1 2 3 ... 66 67 68  next pagenext page


Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] [LSE] Business Portal 650x300px

» top